Drug-resistant bacteria constantly morph and evolve, eluding efforts to kill them. But after about a dozen years of persistence, a husband-and-wife team of medicinal chemists and their students at UConn’s School of Pharmacy have developed a group of experimental antibiotics that early tests suggest may be up to the job.